Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease.

Source:http://linkedlifedata.com/resource/pubmed/id/3499218

Cancer Res. 1987 Nov 1 47 21 5725-32

Download in:

View as

Triples

General Info

PMID
3499218